Industry: Chemical & Material
Published Date: 2024-01-25
Pages: 122 Pages
Report ld: 2356578
Request Sample
Customized Report
Pharmaceutical Grade Niacin Market Size(US$)

CAGR 2024-2030
5.1%
Market Size,2030
USD 842.5
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 593.8 million in 2023 and is forecast to a readjusted size of US$ 842.5 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
MARKET SEGMENTATION
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Grade Niacin, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Pharmaceutical Grade Niacin by region & country, by Type, and by Application.
The Pharmaceutical Grade Niacin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Grade Niacin.
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Pharmaceutical Grade Niacin manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Pharmaceutical Grade Niacin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Pharmaceutical Grade Niacin in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 Pharmaceutical Grade Niacin Product Introduction
1.2 Global Pharmaceutical Grade Niacin Market Size Forecast
1.2.1 Global Pharmaceutical Grade Niacin Sales Value (2019-2030)
1.2.2 Global Pharmaceutical Grade Niacin Sales Volume (2019-2030)
1.2.3 Global Pharmaceutical Grade Niacin Sales Price (2019-2030)
1.3 Pharmaceutical Grade Niacin Market Trends & Drivers
1.3.1 Pharmaceutical Grade Niacin Industry Trends
1.3.2 Pharmaceutical Grade Niacin Market Drivers & Opportunity
1.3.3 Pharmaceutical Grade Niacin Market Challenges
1.3.4 Pharmaceutical Grade Niacin Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Pharmaceutical Grade Niacin Players Revenue Ranking (2023)
2.2 Global Pharmaceutical Grade Niacin Revenue by Company (2019-2024)
2.3 Global Pharmaceutical Grade Niacin Players Sales Volume Ranking (2023)
2.4 Global Pharmaceutical Grade Niacin Sales Volume by Company Players (2019-2024)
2.5 Global Pharmaceutical Grade Niacin Average Price by Company (2019-2024)
2.6 Key Manufacturers Pharmaceutical Grade Niacin Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Pharmaceutical Grade Niacin Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Pharmaceutical Grade Niacin
2.9 Pharmaceutical Grade Niacin Market Competitive Analysis
2.9.1 Pharmaceutical Grade Niacin Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Pharmaceutical Grade Niacin Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Grade Niacin as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Crystal
3.1.2 Powder
3.2 Global Pharmaceutical Grade Niacin Sales Value by Type
3.2.1 Global Pharmaceutical Grade Niacin Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Pharmaceutical Grade Niacin Sales Value, by Type (2019-2030)
3.2.3 Global Pharmaceutical Grade Niacin Sales Value, by Type (%) (2019-2030)
3.3 Global Pharmaceutical Grade Niacin Sales Volume by Type
3.3.1 Global Pharmaceutical Grade Niacin Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Pharmaceutical Grade Niacin Sales Volume, by Type (2019-2030)
3.3.3 Global Pharmaceutical Grade Niacin Sales Volume, by Type (%) (2019-2030)
3.4 Global Pharmaceutical Grade Niacin Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Pharmaceutical Industry
4.1.2 Daily Chemicals
4.1.3 Others
4.2 Global Pharmaceutical Grade Niacin Sales Value by Application
4.2.1 Global Pharmaceutical Grade Niacin Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Pharmaceutical Grade Niacin Sales Value, by Application (2019-2030)
4.2.3 Global Pharmaceutical Grade Niacin Sales Value, by Application (%) (2019-2030)
4.3 Global Pharmaceutical Grade Niacin Sales Volume by Application
4.3.1 Global Pharmaceutical Grade Niacin Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Pharmaceutical Grade Niacin Sales Volume, by Application (2019-2030)
4.3.3 Global Pharmaceutical Grade Niacin Sales Volume, by Application (%) (2019-2030)
4.4 Global Pharmaceutical Grade Niacin Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Pharmaceutical Grade Niacin Sales Value by Region
5.1.1 Global Pharmaceutical Grade Niacin Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Pharmaceutical Grade Niacin Sales Value by Region (2019-2024)
5.1.3 Global Pharmaceutical Grade Niacin Sales Value by Region (2025-2030)
5.1.4 Global Pharmaceutical Grade Niacin Sales Value by Region (%), (2019-2030)
5.2 Global Pharmaceutical Grade Niacin Sales Volume by Region
5.2.1 Global Pharmaceutical Grade Niacin Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Pharmaceutical Grade Niacin Sales Volume by Region (2019-2024)
5.2.3 Global Pharmaceutical Grade Niacin Sales Volume by Region (2025-2030)
5.2.4 Global Pharmaceutical Grade Niacin Sales Volume by Region (%), (2019-2030)
5.3 Global Pharmaceutical Grade Niacin Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Pharmaceutical Grade Niacin Sales Value, 2019-2030
5.4.2 North America Pharmaceutical Grade Niacin Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Pharmaceutical Grade Niacin Sales Value, 2019-2030
5.5.2 Europe Pharmaceutical Grade Niacin Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Pharmaceutical Grade Niacin Sales Value, 2019-2030
5.6.2 Asia Pacific Pharmaceutical Grade Niacin Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Pharmaceutical Grade Niacin Sales Value, 2019-2030
5.7.2 South America Pharmaceutical Grade Niacin Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Pharmaceutical Grade Niacin Sales Value, 2019-2030
5.8.2 Middle East & Africa Pharmaceutical Grade Niacin Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Pharmaceutical Grade Niacin Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Pharmaceutical Grade Niacin Sales Value
6.2.1 Key Countries/Regions Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.2.2 Key Countries/Regions Pharmaceutical Grade Niacin Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.3.2 United States Pharmaceutical Grade Niacin Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Pharmaceutical Grade Niacin Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.4.2 Europe Pharmaceutical Grade Niacin Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Pharmaceutical Grade Niacin Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.5.2 China Pharmaceutical Grade Niacin Sales Value by Type (%), 2023 VS 2030
6.5.3 China Pharmaceutical Grade Niacin Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.6.2 Japan Pharmaceutical Grade Niacin Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Pharmaceutical Grade Niacin Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.7.2 South Korea Pharmaceutical Grade Niacin Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Pharmaceutical Grade Niacin Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.8.2 Southeast Asia Pharmaceutical Grade Niacin Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Pharmaceutical Grade Niacin Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Pharmaceutical Grade Niacin Sales Value, 2019-2030
6.9.2 India Pharmaceutical Grade Niacin Sales Value by Type (%), 2023 VS 2030
6.9.3 India Pharmaceutical Grade Niacin Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Lonza
7.1.1 Lonza Company Information
7.1.2 Lonza Introduction and Business Overview
7.1.3 Lonza Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Lonza Pharmaceutical Grade Niacin Product Offerings
7.1.5 Lonza Recent Development
7.2 Jubilant Life Sciences
7.2.1 Jubilant Life Sciences Company Information
7.2.2 Jubilant Life Sciences Introduction and Business Overview
7.2.3 Jubilant Life Sciences Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Jubilant Life Sciences Pharmaceutical Grade Niacin Product Offerings
7.2.5 Jubilant Life Sciences Recent Development
7.3 Vertellus
7.3.1 Vertellus Company Information
7.3.2 Vertellus Introduction and Business Overview
7.3.3 Vertellus Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Vertellus Pharmaceutical Grade Niacin Product Offerings
7.3.5 Vertellus Recent Development
7.4 Brother Enterprises
7.4.1 Brother Enterprises Company Information
7.4.2 Brother Enterprises Introduction and Business Overview
7.4.3 Brother Enterprises Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Brother Enterprises Pharmaceutical Grade Niacin Product Offerings
7.4.5 Brother Enterprises Recent Development
7.5 Zhejiang Lanbo Biotechnology
7.5.1 Zhejiang Lanbo Biotechnology Company Information
7.5.2 Zhejiang Lanbo Biotechnology Introduction and Business Overview
7.5.3 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Zhejiang Lanbo Biotechnology Pharmaceutical Grade Niacin Product Offerings
7.5.5 Zhejiang Lanbo Biotechnology Recent Development
7.6 Lasons India
7.6.1 Lasons India Company Information
7.6.2 Lasons India Introduction and Business Overview
7.6.3 Lasons India Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Lasons India Pharmaceutical Grade Niacin Product Offerings
7.6.5 Lasons India Recent Development
7.7 Vanetta
7.7.1 Vanetta Company Information
7.7.2 Vanetta Introduction and Business Overview
7.7.3 Vanetta Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Vanetta Pharmaceutical Grade Niacin Product Offerings
7.7.5 Vanetta Recent Development
7.8 DSM
7.8.1 DSM Company Information
7.8.2 DSM Introduction and Business Overview
7.8.3 DSM Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.8.4 DSM Pharmaceutical Grade Niacin Product Offerings
7.8.5 DSM Recent Development
7.9 Tianjin Zhongrui Pharmaceutical
7.9.1 Tianjin Zhongrui Pharmaceutical Company Information
7.9.2 Tianjin Zhongrui Pharmaceutical Introduction and Business Overview
7.9.3 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Tianjin Zhongrui Pharmaceutical Pharmaceutical Grade Niacin Product Offerings
7.9.5 Tianjin Zhongrui Pharmaceutical Recent Development
7.10 Resonance Specialties
7.10.1 Resonance Specialties Company Information
7.10.2 Resonance Specialties Introduction and Business Overview
7.10.3 Resonance Specialties Pharmaceutical Grade Niacin Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Resonance Specialties Pharmaceutical Grade Niacin Product Offerings
7.10.5 Resonance Specialties Recent Development
8 Industry Chain Analysis
8.1 Pharmaceutical Grade Niacin Industrial Chain
8.2 Pharmaceutical Grade Niacin Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Pharmaceutical Grade Niacin Sales Model
8.5.2 Sales Channel
8.5.3 Pharmaceutical Grade Niacin Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 105
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Niacin market was valued at US$ 683 million in 2025 and is anticipated to reach US$ 965 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published Date: 2026-02-01
Pages: 134
USD 2900.00
(Single User License)
The global Pharmaceutical Grade Niacin market is projected to grow from US$ 653 million in 2024 to US$ 922 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-03
Pages: 136
USD 4900.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 91
USD 3950.00
(Single User License)
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published Date: 2025-02-14
Pages: 80
USD 4250.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was valued at US$ 653 million in the year 2024 and is projected to reach a revised size of US$ 922 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published Date: 2025-02-14
Pages: 94
USD 2900.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-04-10
Pages: 112
USD 4900.00
(Single User License)
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published Date: 2024-02-05
Pages: 96
USD 2900.00
(Single User License)
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 683 million in 2025 and is projected to reach US$ 965 million, growing at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-01
Pages: 105
The global Pharmaceutical Grade Niacin market was valued at US$ 683 million in 2025 and is anticipated to reach US$ 965 million by 2032, at a CAGR of 5.1% from 2026 to 2032.
Published: 2026-02-01
Pages: 134
The global Pharmaceutical Grade Niacin market is projected to grow from US$ 653 million in 2024 to US$ 922 million by 2031, at a CAGR of 5.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-03
Pages: 136
The global market for Pharmaceutical Grade Niacin was estimated to be worth US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 91
The global Pharmaceutical Grade Niacin market size was US$ 653 million in 2024 and is forecast to a readjusted size of US$ 922 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.
Published: 2025-02-14
Pages: 80
The global market for Pharmaceutical Grade Niacin was valued at US$ 653 million in the year 2024 and is projected to reach a revised size of US$ 922 million by 2031, growing at a CAGR of 5.1% during the forecast period.
Published: 2025-02-14
Pages: 94
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-04-10
Pages: 112
Niacin is a B vitamin that the body makes and uses to convert food into energy. It helps maintain the health of the nervous system, digestive system and skin.
Published: 2024-02-05
Pages: 96
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
REPORT SCOPE
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now